CareLoop Health

CareLoop Health Ltd, founded in 2022 in Manchester, UK, provides digital health solutions targeted at serious mental health conditions. The company was established in response to the growing need for technology-driven support in mental healthcare. The founder’s history prior to CareLoop is not publicly available. CareLoop Health has completed a total of 1 deal, with the most recent deal occurring on January 30, 2025.8 million, with contributions from Johnson & Johnson Impact Ventures, Praetura Ventures, SFC Capital, and Verge HealthTech. Zoe Blake (CEO), Pauline Whelan, Prof. John Ainsworth, Prof. Shon Lewis, and Prof. Sandra Bucci co-founded the firm. CareLoop Health specializes in providing digital health solutions aimed at transforming mental healthcare, particularly for individuals with severe mental health conditions such as psychosis and schizophrenia. Their flagship product, the “P4-DTxMedicine” platform, utilizes AI-driven analytics to predict early warning signs of mental health crises, facilitating timely intervention and personalized care strategies. This platform has been co-designed through collaboration with patients, clinicians, software engineers, and researchers, ensuring that it addresses real-world challenges faced by users. CareLoop's services are designed to complement traditional in-person care, thus enhancing the overall treatment experience for patients. The primary user base includes healthcare providers, mental health professionals, and patients across the United Kingdom, with ongoing research and development efforts extending their reach to international markets.  CareLoop Health generates revenue through partnerships and subscription-based models with healthcare organizations and mental health professionals. The company engages in B2B transactions, offering tailored solutions that integrate seamlessly with existing care pathways. Clients may subscribe to the platform for access to its predictive analytics and personalized care tools, which are designed to improve patient outcomes and reduce hospital admissions. CareLoop’s client base includes NHS trusts and private mental health organizations, which utilize their AI-powered platform for monitoring and intervention in severe mental health cases. Specific pricing structures are determined based on the scope of services required, reflecting the customized nature of their offerings and the varying needs of their clients. CareLoop plans to launch these new features within the next year, thus enhancing its product offerings. Additionally, they aim to expand their services into European markets, targeting regions with high demand for mental health solutions by the end of 2026.

1. Seed

   Jan 30, 2025

   Amount

   $2.3M

   Investors

   Locked